Latest AI and machine learning research in lung cancer for healthcare professionals.
Lung adenocarcinoma (LUAD), the most common subtype of non–small cell lung cancer (NSCLC) exhibits profound histological and molecular heterogeneity, hindering accurate prognosis and effective treatment. Current approaches to assess this heterogeneity, such as histopathology, molecular profiling, and spatial transcriptomics are constrained by high costs, long turnaround times, and limited tissue a...
Breast cancer (BRCA) is a leading cause of cancer-related mortality in women, characterized by marked heterogeneity in molecular subtypes, immune microenvironment, and therapeutic response. Current gene expression classifiers often lack mechanistic grounding, limiting their clinical utility. Using an integrated machine learning approach, we identified a four-gene panel, FOXO4, EGFR, FGF2, and CDKN...
The molecular landscape of lung adenocarcinoma (LUAD) is often summarized as a “pie chart” of driver oncogenes, suggesting identification and targetin...
Bladder cancer (BCa) diagnosis typically relies on invasive cystoscopy, which is effective but costly and uncomfortable. Urinary microRNAs (miRNAs), e...
Accurate and timely diagnosis of colorectal cancer (CRC) is essential for effective treatment and better patient outcomes. This study explores the app...
Histologically stained tissue sections are considered the gold standard for studying microscopic anatomy and diagnosing disease in clinical practice. ...
Spaceflight presents unique environmental stressors, such as microgravity and radiation, that significantly affect biological systems at the molecular...
Despite growing evidence implicating cellular senescence in tumor progression, methodological challenges in objectively quantifying senescent cell bur...
Preclinical models are used extensively to study diseases and potential therapeutic treatments. Complex in vitro platforms incorporating human cellula...
Traditional machine learning approaches for text or sequence classification rely on converting textual data into numerical representations. In this st...
Tertiary lymphoid structures (TLS) have been observed in solid tumors and have been associated with better outcomes in patients treated with immunothe...
Immune checkpoint blockade has emerged as a promising form of cancer therapy. However, only some patients respond to checkpoint inhibitors, while a si...
A comprehensive understanding of cancer progression requires integrating tissue morphol-ogy with spatial molecular profiles. We present SHEST, a multi...
Therapeutic antibody design is a complex multi-property optimization problem with substantial promise for improvement with the application of machine-...
Complex multilineage organoid systems lack quantitative phenotyping methods preserving spatial architecture at high throughput. Current approaches com...
Applications of artificial intelligence (AI) to histopathology are now common, but most require supervision which inherently limits their scope. By us...
Pancreatic ductal adenocarcinoma (PDAC) lacks reliable prognostic biomarkers. RNA-based signatures suffer from poor reproducibility due to batch effec...
Prostate cancer is the second most common cancer in men across the United States, of which prostate adenocarcinoma (PRAD) is the most common subtype. ...
Due to the late detection, aggressive nature, and paucity of treatment options, pancreatic adenocarcinoma (PAAD) remains one of the most lethal cancer...
Dissecting the heterogeneous response of individual cells towards genetic and chemical perturbations is central to understanding the dynamic functions...